Chairman and CEO: Wafik Bardissi
Market value: $89 million
Minapharm Pharmaceuticals’ history dates back to the 1950s when the first privately-owned factory in Egypt, Heliopolis Pharmaceutical Laboratories, was established. It stopped its activities in the 1960s and was re-established as Minapharm Pharmaceuticals in 1992. It employs 1,400 people. In May 2021, Minapharm Pharmaceuticals and its wholly-owned Berlin-based subsidiary, ProBioGen AG, announced the establishment of ProBioGen’s subsidiary MiGenTra in Berlin.